Automatic Website Traffic RSS

Predictive model of oxaliplatin-induced liver injury based on artificial neural network and logistic regression

The medical information of patients treated with oxaliplatin between May and November 2016 at 10 hospitals was collected prospectively. The researchers used the updated Roussel Uclaf causality ... read more

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

The current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorouracil, leucovorin, and oxaliplatin. read more

Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials

In patients ≥70 years with stage III CC fit enough to be enrolled in clinical trials, oxaliplatin-based adjuvant chemotherapy was well tolerated and led to similar TTR compared with younger patients, ... read more

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for ... read more

'I ignored red flag symptom when I went to the toilet - then I got devastating diagnosis'

EXCLUSIVE: Gran Geraldine Dennis wasn't too concerned about her symptoms until she began losing weight - then she received devastating news. read more

DBL Oxaliplatin

All medicines have risks and benefits. Your doctor has weighed the risks of you using oxaliplatin against the benefits they expect it will have for you. If you have any concerns about taking this ... read more

Coxatin (Oxaliplatin) Drug Price and Information

Medindia neither buys nor sells drugs. Oxaliplatin (Coxatin) is an antineoplastic agent, prescribed for colorectal cancer either alone or with other medications.It works by killing cancer cells ... read more

Oxaliplatin in Older Adults With Resected Colorectal Cancer?

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ... read more

Kerr on Oncology

Medscape Oncology, March 08, 2024 Oxaliplatin in Older Adults With Resected Colorectal Cancer? Dr David Kerr discusses the use of adjuvant chemotherapy with oxaliplatin to high-risk patients with ... read more

Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025

The incremental benefits in median survival have been modest in the past 11 years with the recent approval of Onivyde in the NALIRIFOX regimen demonstrating a 1.9 month survival benefit compared to ... read more

Gene expression profiling of oxaliplatin-resistant cell lines

We compared the gene expression patterns of oxaliplatin-resistant cell lines with the patterns of their sensitive counterparts in an attempt to discover universal mechanisms that characterize ... read more